Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!




January 23 - 25 2015, 12:00 AM - 12:00 AM


February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit



November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur


FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled


Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled

November 07, 2014

FDA MedWatch - Nellcor Puritan Bennett, 980 Ventilator System: Class I Recall - Software Issue May Stop Ventilator


FDA MedWatch Nellcor Puritan Bennett 980 Ventilator System Class I Recall



Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

Congressional Researchers Question IPAB

Tuesday, December 21, 2010

A recently obtained report authored by the non-partisan Congressional Research Service (CRS) raises questions about the Independent Payment Advisory Board (IPAB), a draconian Medicare cost-cutting mechanism created by the new health care reform law, the Patient Protection and Affordable Care Act (PPACA).

The reform law created the IPAB as a novel and aggressive mechanism to “reduce the per capita rate of growth in Medicare spending.” The Board, composed of 15 members appointed by the President, is charged with developing proposals to maintain Medicare spending below a targeted per capita growth rate.  In a process reminiscent of that used for the Defense Base Realignment and Closure (BRAC) Commission, the Board’s proposals receive special expedited and protected consideration by Congress.  The process spelled out in the statute creates a number of barriers that inhibit Congress’ ability to reject or defeat any proposed Medicare cuts.    

The CRS report highlights that the IPAB provision may be open to legal challenges because the law shifts the “balance of power to the executive branch and away from Congress.” The report also questions how the IPAB procedures will impact House and Senate parliamentary procedures and the constitutional rights of both chambers. 

Currently, the constitutionality of the Board is being challenged in federal district court in Arizona by the Goldwater Institute.

ASA opposed the inclusion of IPAB during the health system reform debate and currently supports repeal of the provision creating the Board.         

« Back to Washington Alerts